Our Recommendations
New Publications
- Filariasis linfática - Datos y cifras (2022)
- Lymphatic filariasis - Key facts (2022)
- Лимфатический филяриоз - Основные факты (2022)
- Filariose lymphatique - Principaux faits (2022)
- Development and Introduction of the Filariasis Test Strip: A New Diagnostic Test for the Global Program to Eliminate Lymphatic Filariasis (2022)
Filter
50
Featured
Language
Document type
Studies & Reports
25
Manuals
6
Videos
6
Guidelines
5
Strategic & Response Plan
4
Infographics
2
Training Material
1
Fact sheets
1
Countries / Regions
Global
22
Africa
2
Latin America and the Carribbean
2
Ghana
1
Saudi Arabia
1
Western Pacific Region
1
Djibouti
1
Egypt
1
Sudan
1
Yemen
1
Zambia
1
Somalia
1
India
1
Authors & Publishers
Publication Years
Category
Lymphaticfilariasis
5
Countries
4
Trachoma
2
Leprosy
2
Chagas
1
Studies & Reports
1
NTDs & Others
1
Toolboxes
Studies & Reports
14
Capacity Building & Resources
9
Prevention & Control
9
Clinical Aspects & Diagnostics
8
Information & Education Material (IEC)
7
Statistics & Facts
7
Clinical Aspects & Diagnostics
2
Clinical Aspects & Diagnostics
2
Clinical Guidelines
1
Strategies & Action Plans
1
International
1
Supporting tools
1
Information & Education Material (IEC)
1
Onchocerciasis
1
Training in monitoring and epidemiological assessment of mass drug administration for eliminating lymphatic filariasis: learners’ guide. World Health Organization.
Formation sur le suivi et l’évaluation épidémiologique du traitement médicamenteux de masse pour l’élimination de la filariose lymphatique : guide des apprenants. Organisation mondiale de la Santé.
Lymphatic filariasis (LF) is a parasitic disease that is a major cause of chronic disability in the developing world. According to the 2021–2030 road map for neglected tropical diseases (NTDs) published by the World Health Organization (WHO), the global goal for LF is elimination as a public healt...
Dickson and Daniel discuss lymphatic filariasis caused by the helminths Wuchereria bancrofti and Brugia malayai.
During the 17 years since Surgical approaches to the urogenital manifestations of lymphatic filariasis was first published, there has been heightened awareness of the physical, economic and emotional burden of the genitourinary manifestations of filariasis. With the impetus to provide better guidanc...
Lymphatic filariasis (LF) is an avoidable, debilitating, disfiguring disease caused by infection with the filarial parasites Wuchereria bancrofti, Brugia malayi and B. timori. Globally, 51.4 million people are
estimated to be infected. Lymphoedema and hydrocoele are the visible, chronic clinical co...
La filariose lymphatique (FL) est une maladie évitable, incapacitante et défigurante, due à une infestation par des filaires parasites des espèces Wuchereria bancrofti, Brugia malayi et B. timori. On estime que 51,4 millions de personnes sont infectées dans le monde. Le lymphœdème et l’hydr...
Lymphatic filariasis, commonly known as elephantiasis, is a neglected tropical disease. Infection occurs when filarial parasites are transmitted to humans through mosquitoes. Infection is usually acquired in childhood causing hidden damage to the lymphatic system.
La filariasis linfática, conocida generalmente como elefantiasis, es una enfermedad tropical desatendida. La infección humana se produce por la transmisión de unos parásitos denominados filarias a través de los mosquitos. La infección se contrae generalmente en la infancia y provoca daños no ...
La filariose lymphatique, communément appelée éléphantiasis, est une maladie tropicale négligée. L’infection se produit lorsque les parasites filaires responsables de la maladie sont transmis à l’homme par des moustiques. Généralement contractée dans l’enfance, cette infection provoq...
Лимфатический филяриоз, известный как слоновость, относится к числу забытых тропических болезней. Инвазия происходит в результате передачи паразитов человеку пр...
يُعد داء الفيلاريات اللمفي المعروف بداء الفيل أحد أمراض المناطق المدارية المُهمَلة. وتحدث العدوى بهذا المرض عندما تنتقل الطفيليات الفيلارية إلى الإنسان عن طريق ال...
Since the launch of the Global Programme to Eliminate Lymphatic Filariasis (GPELF) in 2000, more than 910 million people have received preventive chemotherapy for lymphatic filariasis (LF) and many thousands have received care for chronic manifestations of the disease. To achieve this, millions of c...
The South-East Asia regional programme to eliminate lymphatic filariasis (LF) was launched in 2000. This study presents the progress and impact of the programme in the region.
Lymphatic filariasis, commonly known as elephantiasis, is a neglected tropical disease. Infection occurs when filarial parasites are transmitted to humans through mosquitoes. When a mosquito with infective stage larvae bites a person, the parasites are deposited on the person’s skin from where the...
Un suivi et une évaluation efficaces sont nécessaires pour atteindre l’objectif d’élimination de la filariose lymphatique (FL). Après le traitement médicamenteux de masse (TMM) conformément aux lignes directrices élaborées par l’OMS, des programmes doivent être mis en œuvre afin de d...
Le but de cette note de concept est donc de définir Ie rôle de I'APOC dans I'élimination de l'onchocercose, ainsi que sa contribution aux efforts visant à éliminer la filariose
Iymphatique et d'autres maladies tropicales négligées ciblées, et au renforcement des
systèmes de santé au nive...
Effective monitoring, epidemiological assessment and evaluation are necessary to achieve the aim of interrupting LF transmission. This manual is designed to ensure that national elimination programmes have available the best information on methodologies and procedures for monitoring MDA, appropriate...
Monitoramento efetivo, avaliação epidemiológica e análise subsequente são
necessários para atingir o objetivo de interromper a transmissão da FL. Este manual foi
elaborado para oferecer aos programas nacionais de eliminação da fi lariose informação de qualidade sobre metodologias e proc...
The content of these guidelines goes beyond the technicalities of medical needs with additional insights into community empowerment, possible access to welfare and economic opportunities and similar issues. If these are adequately explored, the health and quality of life of people affected and their...
